KORRINE CORTEZ-ROLBAND: Open Payments
NPI 1033707856 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 74 payments from 20 companies in 2025. Trend: 2023 $530 · 2024 $1,757 · 2025 $1,398
Food & beverage: $1,398
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $217 |
| AstraZeneca Pharmaceuticals LP | 8 | $146 |
| Lilly USA, LLC | 9 | $142 |
| GlaxoSmithKline, LLC. | 7 | $141 |
| Novo Nordisk Inc | 8 | $138 |
| PFIZER INC. | 6 | $121 |
| Sumitomo Pharma America, Inc. | 4 | $102 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $49 |
| Amgen Inc. | 3 | $49 |
Products named: MOUNJARO, SHINGRIX, UBRELVY, GEMTESA, QULIPTA, AIRSUPRA, Wegovy, Ozempic.
Industry payments across NC — which companies pay providers there.
